We are live on
!
Find out more
ACM
Athyrium Capital Management Portfolio holdings
AUM
$8.69M
1-Year Est. Return
34.58%
This Fund
S&P 500
This Quarter
Est. Return
-23.96%
1 Year Est. Return
-34.58%
3 Year Est. Return
-25.1%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$208M
AUM Growth
–
Cap. Flow
+$218M
Cap. Flow
% of AUM
104.84%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
|
+$159M |
| 2 |
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
|
+$59M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
BGC
RVM
JDR
DA
KIM
RJTCONH
HSC
HVM
Athyrium Capital Management's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Athyrium Capital Management, which disclosed 2 positions worth $208M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Biora Therapeutics, Inc. Common Stock: 108,127 shares worth $144M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Athyrium Capital Management's largest Q4 2020 buy was Biora Therapeutics, Inc. Common Stock: 108,127 shares worth $144M.
- Athyrium Capital Management's ten largest holdings make up 100% of its $208M portfolio in Q4 2020.
- Athyrium Capital Management disclosed 2 positions in Q4 2020, its first 13F filing on record.
Based on Athyrium Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.